Real-world follow-up of Inari Medical devices in people with pulmonary embolism
Collects real-world information on Inari Medical devices used in adults with pulmonary embolism.
Key facts
- Who runs it
- Inari Medical
- Where
- France, Germany, Italy, Portugal, and United Kingdom14 sites in 5 countriesChoose a country to see its sites
- Trial code
- Registry title
- Inari VISION Registry
- Status
- Recruiting
- People taking part
- 1,000 people, planned
- Started
- 7 Mar 2025
- Expected to end
- 31 Dec 2029
- Type of study
- Observational
- Treatments tested
- Inari Medical Commercially Available Devices
- Record updated
- 5 November 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with pulmonary embolism (a blood clot in the lungs) who have been treated with an Inari Medical device. It collects data on how these devices work in everyday use.
- Age
- 18 years and older
- Sex
- All sexes
- Disease stage
- Pulmonary embolism
- Earlier treatment
- People must have been treated with an Inari Medical device that the registry includes. They must still be within the enrolment time window after their procedure. If the procedure does not take place, the person cannot join.
Main reasons for not taking part
- Not able to attend registry follow-up, now or later
- Pregnant or breastfeeding at the time of enrolment
- Taking part now, or planning to, in another drug or device study that the doctor thinks would interfere
- Meets exclusion rules set by local requirements
The registry criteria, word for word
Show all 8 criteriaShow less
Who can take part
- Willing and able to provide informed consent per institution and geographical requirements
- Has received treatment with an eligible Inari Medical device. NOTE: If patients are consented prior to their procedure and the procedure does not take place, the patient will be considered a screen failure
- Currently within enrollment window relative to their procedure
- Age ≥ 18 years
Who cannot take part
- Current or planned participation in another drug or device study that, in the investigator's opinion, would interfere with participation in this registry
- Is or will be inaccessible for registry follow-up
- Meets exclusion criteria required by local requirements
- Is pregnant or breastfeeding at the time of enrollment
This trial has no sites in United States.
It has sites in 5 countries. Choose a country to see its sites.
About the trial
What the trial wants to find out
This registry is a global prospective, non-randomized, multicenter, observational, active post-market data collection of Inari Medical devices and products.
Treatments tested
- Inari Medical Commercially Available Devices
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Inari VISION Registry
- Plain-language title
- Real-world follow-up of Inari Medical devices in people with pulmonary embolismGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 15 November 2026.
- Record updated
- 5 November 2026